Drug development
The company is responsible for developing next-generation drugs within SK Group.
Source: LinkedIn company description · Retrieved October 13, 2026
Within SK Group, the company is responsible for developing next-generation drugs. The company has been developing drug candidates in the CNS area, with clinical development led by SK Life Science in the United States and research conducted at a center in Pangyo Techno-valley, Gyeonggi-do.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is responsible for developing next-generation drugs within SK Group.
Source: LinkedIn company description · Retrieved October 13, 2026
The company has a research center in Pangyo Techno-valley, Gyeonggi-do.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 16, 2026, September 17, 2026, September 18, 2026, October 7, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.